Review
doi: 10.1007/978-3-642-81488-4_26.
Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A
- PMID: 7003659
- DOI: 10.1007/978-3-642-81488-4_26
Item in Clipboard
Review
Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A
Recent Results Cancer Res.
1980.
Abstract
Fundamental and clinical studies on a new yellow anthracycline antibiotic aclacinomycin A are reviewed. Favorable responses were seen in patients with acute leukemia refractory to daunomycin and adriamycin, malignant lymphoma, and breast, ovarian, lung, gastric, intestinal, and urinary bladder cancers by intravenous and intraperitoneal infusions or bladder instillation of aclacinomycin A alone in the phase II study.
Similar articles
-
A phase II study of aclacinomycin A in acute leukemia in adults.Cancer Treat Rev. 1980 Dec;7(4):177-82. doi: 10.1016/s0305-7372(80)80033-8. Cancer Treat Rev. 1980. PMID: 6938305 No abstract available.
-
Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.Cancer Treat Rep. 1982 Aug;66(8):1619-23. Cancer Treat Rep. 1982. PMID: 6955022
-
Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphoma.Am J Clin Oncol. 1983 Feb;6(1):81-4. Am J Clin Oncol. 1983. PMID: 6573124 No abstract available.
-
The anthracycline antineoplastic drugs.N Engl J Med. 1981 Jul 16;305(3):139-53. doi: 10.1056/NEJM198107163050305. N Engl J Med. 1981. PMID: 7017406 Review. No abstract available.
-
Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.Drugs Exp Clin Res. 1986;12(1-3):275-82. Drugs Exp Clin Res. 1986. PMID: 3525076 Review.
Cited by
-
Preclinical evaluation of aclacinomycin A for the intraperitoneal treatment of human ovarian carcinoma.Cancer Chemother Pharmacol. 1986;18(2):153-6. doi: 10.1007/BF00262286. Cancer Chemother Pharmacol. 1986. PMID: 3466726
-
Sensitive enzyme immunoassay for the quantification of aclacinomycin A using beta-D-galactosidase as a label.Cancer Chemother Pharmacol. 1985;14(1):53-8. doi: 10.1007/BF00552726. Cancer Chemother Pharmacol. 1985. PMID: 3917377
-
Induction of chromosomal aberrations by the anthracycline antitumor antibiotics N,N-dimethyldaunomycin and aclacinomycin A.Experientia. 1987 May 15;43(5):586-8. doi: 10.1007/BF02143595. Experientia. 1987. PMID: 3472901
-
Growth inhibition of human Tenon's capsule fibroblasts and rabbit dermal fibroblasts with non-carcinogenic N-alkylated anthracyclines.Graefes Arch Clin Exp Ophthalmol. 1994 Jun;232(6):347-54. doi: 10.1007/BF00175986. Graefes Arch Clin Exp Ophthalmol. 1994. PMID: 8082842
-
Phase II trial of aclacinomycin A in acute leukemia and various solid tumors.J Cancer Res Clin Oncol. 1983;105(2):162-5. doi: 10.1007/BF00406927. J Cancer Res Clin Oncol. 1983. PMID: 6572190 Free PMC article.